NVP Associates, LLC
CIK 0001545692 · MENLO PARK, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-07 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$328.2M
2026 Q2
Positions
7
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
MBX
MBX BIOSCIENCES INC
35.9%
AVLN
AVALYN PHARMACEUTICALS INC
22.8%
OMDA
OMADA HEALTH INC
16.9%
ZBIO
ZENAS BIOPHARMA INC
14.2%
SNOW
SNOWFLAKE INC
8.9%
GROV
GROVE COLLABORATIVE HOLD INC
1.2%
ONDS
ONDAS INC
0.0%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.